Opportunity
Simpler Grants.gov #RFA-EB-26-003
NIH Forecast: Biomedical Engineering and Imaging Research Support for HBCUs
Buyer
National Institutes of Health
Posted
October 04, 2023
Identifier
RFA-EB-26-003
NAICS
541715, 541714
The National Institutes of Health (NIH), through the National Institute of Biomedical Imaging and Bioengineering, is forecasting a Notice of Funding Opportunity (NOFO) to support research and capacity building at Historically Black Colleges and Universities (HBCUs): - Government Buyer: - National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering - Purpose and Scope: - Support for bioengineering and imaging research capacity, technology innovation, education, and research training at HBCUs - Initiative aligns with the HBCU PARTNERS Act and Executive Order 14283 - Aims to strengthen HBCUs' competitiveness for federal research and development funding - Program Details: - NOFO will use the UG3/UH3 activity code - Encourages collaborative projects combining bioengineering, imaging, and technology development with biomedical expertise - Products/Services: - No specific OEMs, vendors, products, or services are identified at this stage - No part numbers or quantities specified - Unique Requirements: - Focus on HBCU participation and capacity building - Emphasis on collaboration and innovation in biomedical engineering and imaging - Status: - This is a forecasted opportunity; applications are not yet being solicited
Description
The National Institute of Biomedical Imaging and Bioengineering plans to solicit applications to enhance bioengineering and imaging research capacity, technology innovation, education, and research training at Historically Black Colleges and Universities (HBCUs). This initiative aligns with the HBCU PARTNERS Act and Executive Order 14283 to strengthen HBCUs' capacity and competitiveness in federal research funding. The NOFO will use the UG3/UH3 activity code and encourages collaborative investigations combining bioengineering, imaging, and technology development with biomedical expertise. Applications are not currently being solicited to allow time for collaboration development.